Kenvue Inc. (NYSE:KVUE) Stock Holdings Lifted by Renaissance Capital LLC

Renaissance Capital LLC raised its position in shares of Kenvue Inc. (NYSE:KVUE) by 9.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 723,592 shares of the company’s stock after buying an additional 61,330 shares during the period. Kenvue comprises about 10.1% of Renaissance Capital LLC’s investment portfolio, making the stock its biggest holding. Renaissance Capital LLC’s holdings in Kenvue were worth $15,449,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in KVUE. Grove Bank & Trust boosted its holdings in shares of Kenvue by 438.4% during the fourth quarter. Grove Bank & Trust now owns 1,163 shares of the company’s stock worth $25,000 after purchasing an additional 947 shares during the period. Geneos Wealth Management Inc. purchased a new stake in Kenvue in the 4th quarter worth approximately $29,000. Riverview Trust Co purchased a new stake in Kenvue in the 3rd quarter worth approximately $30,000. Fortitude Family Office LLC grew its position in shares of Kenvue by 106.6% in the 4th quarter. Fortitude Family Office LLC now owns 1,506 shares of the company’s stock worth $32,000 after buying an additional 777 shares during the last quarter. Finally, Ashton Thomas Securities LLC purchased a new position in shares of Kenvue during the third quarter valued at approximately $35,000. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

KVUE has been the topic of several recent analyst reports. Piper Sandler upgraded shares of Kenvue from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $21.00 to $26.00 in a report on Monday, January 6th. Royal Bank of Canada reiterated a “sector perform” rating and set a $24.00 price target on shares of Kenvue in a research report on Monday. Bank of America increased their target price on Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Tuesday, October 22nd. Deutsche Bank Aktiengesellschaft lowered Kenvue from a “buy” rating to a “hold” rating and dropped their price target for the company from $25.00 to $24.00 in a research report on Thursday, December 12th. Finally, JPMorgan Chase & Co. raised their price objective on Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $23.08.

Kenvue Stock Performance

Shares of KVUE opened at $21.22 on Tuesday. The company has a market cap of $40.69 billion, a price-to-earnings ratio of 38.59, a P/E/G ratio of 2.05 and a beta of 1.45. The business’s fifty day simple moving average is $21.90 and its two-hundred day simple moving average is $21.92. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The business had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same quarter in the previous year, the firm earned $0.31 EPS. Kenvue’s revenue was down .4% on a year-over-year basis. Research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th will be paid a dividend of $0.205 per share. The ex-dividend date is Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a yield of 3.86%. Kenvue’s dividend payout ratio is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.